CIBC Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.03M Buy
35,788
+1,200
+3% +$299K 0.02% 412
2025
Q4
$8.33M Buy
34,588
+13,920
+67% +$3.56M 0.02% 395
2025
Q3
$5.66M Buy
20,668
+78
+0.4% +$21.3K 0.02% 389
2025
Q2
$5.31M Sell
20,590
-1,854
-8% -$442K 0.02% 392
2025
Q1
$5.02M Sell
22,444
-227
-1% -$53K 0.02% 396
2024
Q4
$5.18M Buy
22,671
+984
+5% +$237K 0.02% 399
2024
Q3
$5.29M Buy
21,687
+1,581
+8% +$353K 0.02% 389
2024
Q2
$3.85M Sell
20,106
-702
-3% -$142K 0.01% 422
2024
Q1
$4.12M Buy
20,808
+629
+3% +$115K 0.01% 423
2023
Q4
$3.47M Sell
20,179
-1,887
-9% -$290K 0.01% 432
2023
Q3
$3.26M Sell
22,066
-203
-0.9% -$36.7K 0.01% 424
2023
Q2
$4.87M Sell
22,269
-213
-0.9% -$47.5K 0.02% 373
2023
Q1
$4.92M Buy
22,482
+570
+3% +$124K 0.02% 375
2022
Q4
$4.56M Buy
21,912
+1,388
+7% +$305K 0.02% 378
2022
Q3
$4.48M Buy
20,524
+1,700
+9% +$387K 0.02% 352
2022
Q2
$3.95M Buy
18,824
+3,836
+26% +$817K 0.02% 367
2022
Q1
$3.63M Buy
14,988
+150
+1% +$36.3K 0.01% 423
2021
Q4
$3.87M Buy
14,838
+552
+4% +$143K 0.01% 418
2021
Q3
$3.77M Sell
14,286
-10,528
-42% -$2.88M 0.02% 408
2021
Q2
$6.12M Sell
24,814
-196,996
-89% -$41.4M 0.02% 318
2021
Q1
$43M Buy
221,810
+15,496
+8% +$3.11M 0.18% 91
2020
Q4
$43.9M Sell
206,314
-15,378
-7% -$3.07M 0.21% 86
2020
Q3
$38M Buy
221,692
+90,281
+69% +$16.7M 0.19% 90
2020
Q2
$25.2M Buy
131,411
+5,638
+4% +$922K 0.15% 100
2020
Q1
$18.5M Buy
125,773
+97,462
+344% +$15.5M 0.13% 112
2019
Q4
$4.39M Buy
28,311
+558
+2% +$80.4K 0.02% 278
2019
Q3
$3.75M Sell
27,753
-3,289
-11% -$431K 0.02% 302
2019
Q2
$3.79M Sell
31,042
-297
-0.9% -$32.9K 0.02% 292
2019
Q1
$3.26M Buy
31,339
+2,097
+7% +$216K 0.02% 316
2018
Q4
$3.33M Sell
29,242
-492
-2% -$52.7K 0.02% 267
2018
Q3
$3.43M Sell
29,734
-366
-1% -$40.1K 0.02% 296
2018
Q2
$3.12M Sell
30,100
-412
-1% -$41.7K 0.02% 304
2018
Q1
$3M Sell
30,512
-2,002
-6% -$189K 0.02% 307
2017
Q4
$2.75M Buy
32,514
+101
+0.3% +$8.34K 0.02% 331
2017
Q3
$2.5M Buy
32,413
+8,649
+36% +$662K 0.02% 348
2017
Q2
$1.85M Sell
23,764
-5,970
-20% -$427K 0.01% 415
2017
Q1
$2.14M Sell
29,734
-788
-3% -$54.5K 0.01% 381
2016
Q4
$1.89M Sell
30,522
-89
-0.3% -$5.45K 0.01% 402
2016
Q3
$1.98M Buy
30,611
+676
+2% +$45K 0.01% 381
2016
Q2
$1.89M Buy
29,935
+2,086
+7% +$123K 0.01% 388
2016
Q1
$1.61M Buy
27,849
+23,610
+557% +$1.34M 0.01% 420
2015
Q4
$228K Hold
4,239
﹤0.01% 818
2015
Q3
$216K Hold
4,239
﹤0.01% 838
2015
Q2
$239K Buy
4,239
+188
+5% +$11.9K ﹤0.01% 854
2015
Q1
$291K Sell
4,051
-36
-0.9% -$2.34K ﹤0.01% 792
2014
Q4
$229K Sell
4,087
-549
-12% -$28.7K ﹤0.01% 843
2014
Q3
$228K Sell
4,636
-19,140
-81% -$975K ﹤0.01% 867
2014
Q2
$1.2M Buy
23,776
+30
+0.1% +$1.49K 0.01% 531
2014
Q1
$1.06M Buy
23,746
+6,112
+35% +$275K 0.01% 564
2013
Q4
$830K Buy
17,634
+450
+3% +$22.8K 0.01% 593
2013
Q3
$908K Sell
17,184
-190
-1% -$9.22K 0.01% 552
2013
Q2
$784K Buy
+17,374
New +$824K 0.01% 568

Other funds holding RMD

CIBC Asset Management's RMD Position: Q1 2026 in Review

CIBC Asset Management increased its ResMed (RMD) stake by 3.5% in Q1 2026, buying an estimated $299K and bringing the position to 35,788 shares worth $8.03M. The position accounts for 0.02% of the portfolio, ranked #412.

CIBC Asset Management first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $43.9M in Q4 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • CIBC Asset Management held 35,788 shares of ResMed worth $8.03M as of Q1 2026.
  • CIBC Asset Management bought 1,200 ResMed shares in Q1 2026, an estimated $299K.
  • ResMed made up 0.02% of CIBC Asset Management's portfolio in Q1 2026, its #412 holding.
  • CIBC Asset Management first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • CIBC Asset Management's ResMed position peaked at $43.9M in Q4 2020.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.